Stay updated with breaking news from Biosolutions Inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Shares of Emergent BioSolutions Inc. (NYSE:EBS – Get Rating) have received a consensus recommendation of “Hold” from the eight research firms that are covering the company, MarketBeat Ratings reports. Two analysts have rated the stock with a sell recommendation, one has given a hold recommendation and two have given a buy recommendation to the company. […]
Emergent BioSolutions Inc. (NYSE:EBS – Get Rating) saw a significant increase in short interest in the month of March. As of March 31st, there was short interest totalling 7,600,000 shares, an increase of 22.4% from the March 15th total of 6,210,000 shares. Approximately 18.7% of the company’s shares are sold short. Based on an average […]
Benchmark upgraded shares of Emergent BioSolutions (NYSE:EBS – Get Rating) from a hold rating to a buy rating in a report released on Monday morning, The Fly reports. Benchmark currently has $22.00 price target on the biopharmaceutical company’s stock. EBS has been the subject of a number of other research reports. TheStreet lowered Emergent BioSolutions […]
Benchmark upgraded shares of Emergent BioSolutions (NYSE:EBS – Get Rating) from a hold rating to a buy rating in a report released on Monday, The Fly reports. Benchmark currently has $22.00 target price on the biopharmaceutical company’s stock. Several other analysts have also weighed in on EBS. TheStreet lowered Emergent BioSolutions from a c- rating […]
The Food and Drug Administration's (FDA) decision to give an opioid overdose antidote over-the-counter status could help as ...